Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 543

Results For "ENT"

9441 News Found

Bruker acquires Tornado Spectral Systems to expand biopharma PAT product portfolio
Medical Device | January 10, 2024

Bruker acquires Tornado Spectral Systems to expand biopharma PAT product portfolio

Tornado will enhance Bruker’s biopharma PAT portfolio with its well-established products


Cipla announces JV with Kemwell Biopharma and Manipal Education & Medical Group
News | January 09, 2024

Cipla announces JV with Kemwell Biopharma and Manipal Education & Medical Group

The primary goal of this joint venture is to develop and commercialise novel cell therapy products for major unmet medical needs in the United States, Japan, and EU regions


Lupin launches second edition of Aptivate Champion Run for Kids
News | January 09, 2024

Lupin launches second edition of Aptivate Champion Run for Kids

Lupin Life encourages children from Mumbai, Thane, and Navi Mumbai to participate in Aptivate Champion Run


Arco Lab acquires an additional 25% stake in Neviton at Rs. 9.22 Cr
News | January 08, 2024

Arco Lab acquires an additional 25% stake in Neviton at Rs. 9.22 Cr

Arco Lab now holds a 50% stake in Neviton


Omniose collaborates with AstraZeneca to research vaccines for serious bacterial diseases
Clinical Trials | January 07, 2024

Omniose collaborates with AstraZeneca to research vaccines for serious bacterial diseases

Collaboration provides AstraZeneca with exclusive rights to Omniose’s proprietary bioconjugation platform to explore potential vaccines for a broad range of bacterial pathogens


Pharmaids Pharmaceuticals to acquire Adita Bio Sys in share swap
News | January 07, 2024

Pharmaids Pharmaceuticals to acquire Adita Bio Sys in share swap

The acquisition of the shares of Adita result in growth opportunities in line with strategic objectives of the company


Cipla EU to form JV in USA
News | January 07, 2024

Cipla EU to form JV in USA


Merck announces Phase 3 trial initiations for 4 Investigational Candidates from hematology and oncology pipeline
Clinical Trials | January 06, 2024

Merck announces Phase 3 trial initiations for 4 Investigational Candidates from hematology and oncology pipeline

Comprehensive clinical development programs being initiated for each investigational candidate


Supriya Lifesciences received GMP certification from ANVISA Brazil
News | January 06, 2024

Supriya Lifesciences received GMP certification from ANVISA Brazil

The clearance of this audit marks the successful registration of 8 APIs with CADIFA